BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

539428

TEJNAKSH

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Tejnaksh Healthcare Limited Share Price Update

As of the latest trading session, Tejnaksh Healthcare Limited share price is currently at ₹ 22, which is down by ₹ -0.03 from its previous closing. Today, the stock has fluctuated between ₹ 21.86 and ₹ 22.47. Over the past year, Tejnaksh Healthcare Limited has achieved a return of -8.58 %. In the last month alone, the return has been 1.10 %. Read More...

Tejnaksh Healthcare Limited fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    44.69

  • P/E Ratio (TTM)

    18.20

  • Beta

    0.57

  • Book Value / share

    11.78

  • Return on equity

    8.28%

  • EPS (TTM)

    1.22

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    0.72

info icon alternate text

Tejnaksh Healthcare Limited Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 2.24
Operating Expense 1.16
Net Profit 0.72
Net Profit Margin (%) 32.14
Earnings Per Share (EPS) 0.36
EBITDA 1.49
Effective Tax Rate (%) 40.49
Particulars SEP 2024 (Values in Cr)
Revenue 1.98
Operating Expense 1.43
Net Profit 0.56
Net Profit Margin (%) 28.28
Earnings Per Share (EPS) 0.31
EBITDA 1.01
Effective Tax Rate (%) 11.11
Particulars JUN 2024 (Values in Cr)
Revenue 2.18
Operating Expense 1.47
Net Profit 0.58
Net Profit Margin (%) 26.60
Earnings Per Share (EPS) 0.29
EBITDA 1.10
Effective Tax Rate (%) 25.64
Particulars MAR 2024 (Values in Cr)
Revenue 2.14
Operating Expense 1.40
Net Profit 0.61
Net Profit Margin (%) 28.50
Earnings Per Share (EPS) 0.30
EBITDA 1.16
Effective Tax Rate (%) 24.69
Particulars DEC 2023 (Values in Cr)
Revenue 2.10
Operating Expense 1.44
Net Profit 0.55
Net Profit Margin (%) 26.19
Earnings Per Share (EPS) 0.27
EBITDA 1.13
Effective Tax Rate (%) 24.65
Particulars MAR 2024 (Values in Cr)
Revenue 8.22
Operating Expense 6.07
Net Profit 1.81
Net Profit Margin (%) 22.01
Earnings Per Share (EPS) 0.89
EBITDA 3.92
Effective Tax Rate (%) 25.51
Particulars MAR 2023 (Values in Cr)
Revenue 7.34
Operating Expense 5.60
Net Profit 1.38
Net Profit Margin (%) 18.80
Earnings Per Share (EPS) 0.68
EBITDA 3.36
Effective Tax Rate (%) 29.59
Particulars MAR 2022 (Values in Cr)
Revenue 8.12
Operating Expense 4.88
Net Profit 2.52
Net Profit Margin (%) 31.03
Earnings Per Share (EPS) 2.48
EBITDA 4.43
Effective Tax Rate (%) 25.22
Particulars MAR 2021 (Values in Cr)
Revenue 8.56
Operating Expense 6.13
Net Profit 2.00
Net Profit Margin (%) 23.36
Earnings Per Share (EPS) 1.97
EBITDA 3.73
Effective Tax Rate (%) 22.77
Particulars MAR 2020 (Values in Cr)
Revenue 11.14
Operating Expense 9.33
Net Profit 1.92
Net Profit Margin (%) 17.23
Earnings Per Share (EPS) 1.89
EBITDA 4.05
Effective Tax Rate (%) 27.81
Particulars MAR 2024 (Values in Cr)
Book Value / Share 11.60
ROE % 7.76
ROCE % 10.64
Total Debt to Total Equity 0.25
EBITDA Margin 32.35
Particulars MAR 2023 (Values in Cr)
Book Value / Share 21.43
ROE % 8.56
ROCE % 11.24
Total Debt to Total Equity 0.32
EBITDA Margin 34.19
Particulars MAR 2022 (Values in Cr)
Book Value / Share 19.75
ROE % 15.03
ROCE % 17.08
Total Debt to Total Equity 0.32
EBITDA Margin 38.72
Particulars MAR 2021 (Values in Cr)
Book Value / Share 17.05
ROE % 12.71
ROCE % 14.10
Total Debt to Total Equity 0.37
EBITDA Margin 32.19
Particulars MAR 2020 (Values in Cr)
Book Value / Share 15.02
ROE % 15.14
ROCE % 17.72
Total Debt to Total Equity 0.48
EBITDA Margin 25.58
Particulars MAR 2024 (Values in Cr)
Book Value / Share 11.21
ROE % 8.28
ROCE % 11.12
Total Debt to Total Equity 0.26
EBITDA Margin 47.81
Particulars MAR 2023 (Values in Cr)
Book Value / Share 20.62
ROE % 6.81
ROCE % 9.41
Total Debt to Total Equity 0.33
EBITDA Margin 45.91
Particulars MAR 2022 (Values in Cr)
Book Value / Share 19.25
ROE % 13.77
ROCE % 15.63
Total Debt to Total Equity 0.33
EBITDA Margin 54.68
Particulars MAR 2021 (Values in Cr)
Book Value / Share 16.76
ROE % 12.48
ROCE % 13.82
Total Debt to Total Equity 0.38
EBITDA Margin 43.69
Particulars MAR 2020 (Values in Cr)
Book Value / Share 14.78
ROE % 13.67
ROCE % 16.39
Total Debt to Total Equity 0.48
EBITDA Margin 35.22
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 4.25
Total Assets 31.35
Total Liabilities 31.35
Total Equity 24.20
Share Outstanding 20314000
Price to Book Ratio 2.07
Return on Assets (%) 5.66
Return on Capital (%) 6.27
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.13
Total Assets 31.22
Total Liabilities 31.22
Total Equity 22.41
Share Outstanding 10156800
Price to Book Ratio 3.34
Return on Assets (%) 5.38
Return on Capital (%) 5.95
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 3.00
Total Assets 29.60
Total Liabilities 29.60
Total Equity 20.59
Share Outstanding 10156800
Price to Book Ratio 8.75
Return on Assets (%) 9.19
Return on Capital (%) 10.13
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.23
Total Assets 24.57
Total Liabilities 24.57
Total Equity 17.76
Share Outstanding 10156800
Price to Book Ratio 4.34
Return on Assets (%) 8.35
Return on Capital (%) 9.35
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.29
Total Assets 24.90
Total Liabilities 24.90
Total Equity 15.68
Share Outstanding 10156800
Price to Book Ratio 2.44
Return on Assets (%) 8.39
Return on Capital (%) 9.38
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 3.94
Total Assets 30.11
Total Liabilities 30.11
Total Equity 22.77
Share Outstanding 20314000
Price to Book Ratio 2.07
Return on Assets (%) 6.01
Return on Capital (%) 6.74
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2.47
Total Assets 29.80
Total Liabilities 29.80
Total Equity 20.94
Share Outstanding 10156800
Price to Book Ratio 3.34
Return on Assets (%) 4.62
Return on Capital (%) 5.13
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.43
Total Assets 28.67
Total Liabilities 28.67
Total Equity 19.55
Share Outstanding 10156800
Price to Book Ratio 8.75
Return on Assets (%) 8.78
Return on Capital (%) 9.73
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.56
Total Assets 23.87
Total Liabilities 23.87
Total Equity 17.02
Share Outstanding 10156800
Price to Book Ratio 4.34
Return on Assets (%) 8.39
Return on Capital (%) 9.43
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.02
Total Assets 24.28
Total Liabilities 24.28
Total Equity 15.01
Share Outstanding 10156800
Price to Book Ratio 2.44
Return on Assets (%) 7.92
Return on Capital (%) 8.88
Particulars MAR 2024 (Values in Cr)
Net Income 2.37
Cash from Operations 4.54
Cash from Investing -1.21
Cash from Financing -2.26
Net change in Cash 0.72
Free Cash Flow 5.25
Particulars MAR 2023 (Values in Cr)
Net Income 2.51
Cash from Operations 1.70
Cash from Investing -1.40
Cash from Financing -1.19
Net change in Cash -0.47
Free Cash Flow 2.52
Particulars MAR 2022 (Values in Cr)
Net Income 3.76
Cash from Operations 8.96
Cash from Investing -10.58
Cash from Financing 1.61
Net change in Cash 0.23
Free Cash Flow 18.04
Particulars MAR 2021 (Values in Cr)
Net Income 2.66
Cash from Operations 0.47
Cash from Investing 1.55
Cash from Financing -2.80
Net change in Cash -0.06
Free Cash Flow 0.91
Particulars MAR 2020 (Values in Cr)
Net Income 2.96
Cash from Operations 1.64
Cash from Investing -1.20
Cash from Financing 0.10
Net change in Cash 0.05
Free Cash Flow 2.72
Particulars MAR 2024 (Values in Cr)
Net Income 2.43
Cash from Operations 4.47
Cash from Investing -1.07
Cash from Financing -2.31
Net change in Cash 0.75
Free Cash Flow 4.90
Particulars MAR 2023 (Values in Cr)
Net Income 1.96
Cash from Operations 1.51
Cash from Investing -0.98
Cash from Financing -1.17
Net change in Cash -0.25
Free Cash Flow 2.20
Particulars MAR 2022 (Values in Cr)
Net Income 3.37
Cash from Operations 8.88
Cash from Investing -10.39
Cash from Financing 1.61
Net change in Cash 0.34
Free Cash Flow 17.74
Particulars MAR 2021 (Values in Cr)
Net Income 2.59
Cash from Operations 0.34
Cash from Investing 1.55
Cash from Financing -2.86
Net change in Cash -0.46
Free Cash Flow 0.78
Particulars MAR 2020 (Values in Cr)
Net Income 2.66
Cash from Operations 1.29
Cash from Investing -1.15
Cash from Financing 0.21
Net change in Cash 0.06
Free Cash Flow 2.31
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6992.60 76.74 13.41 100542.86 5690.80 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 78.74 192.05 4.94 147.57 51.01 / 98.70
SHREE PACETRONIX LTD. 71.00 14.79 1.90 25.56 61.11 / 268.50
TRANSGENE BIOTEK LTD. 3.75 0.00 2.62 28.41 3.22 / 10.84
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6992.60 83.66 12.27 100542.86 5690.80 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 31.25 0.00 -16.74 23.34 28.34 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 5584.95 29.60 6.27 6109.94 3750.00 / 6400.00

Tejnaksh Healthcare Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
22.20 0.77 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 22.40
  • 26 Days 22.80
  • 10 Days 22.60
  • 50 Days 23.00
  • 12 Days 22.70
  • 100 Days 23.60
  • 20 Days 22.70
  • 200 Days 24.40
22.16 PIVOT

First Support

21.67

First Resistance

22.52

Second Support

21.31

Second Resistance

23.01

Third Support

20.82

Third Resistance

23.37

RSI

42.71

ADX

13.24

MACD

-0.05

Williams % R

-69.02

Commodity Channel Index (CCI)

-42.86

Date

2025-04-29

Week

4103.00

Same Day

4370.00

Month

4764.00

1 Year

0.58

3 Year

0.74

Over 1 Month

1.10%

down

Over 1 Year

-8.58%

down

Over 3 Months

-12.16%

down

Over 3 Years

-35.42%

down

Over 6 Months

-12.57%

down

Over 5 Years

0.07%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

Tejnaksh Healthcare Limited shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
26.16%
Promoter Holdings
73.83%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Sheetal Utkarsh Rawandale 294400.0 (1.45%) Public Shareholding
Guntupalli Sivaramakrishna . 273762.0 (1.35%) Public Shareholding
Sonal Lohia 244989.0 (1.21%) Public Shareholding
Utkarsh Vishwas Rawandale 18.0 (0.0%) Shareholding of Promoter and Promoter Group
Pramila Vishwasrao Patil 31018.0 (0.0%) Shareholding of Promoter and Promoter Group
Preeti Ashish Rawandale 7217932.0 (0.0%) Shareholding of Promoter and Promoter Group
Ashish Vishwas Rawandale 7749202.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

Tejnaksh Healthcare Limited corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
28 Apr 2018 26 Apr 2018 36:10
09 Mar 2017 08 Mar 2017 1:1
Ex-Date Old FV NEW FV Record Date
19 Jul 2023 10.0 5.0 19 Jul 2023

Tejnaksh Healthcare Limited Share Price

Tejnaksh Healthcare Limited was incorporated in Mumbai as 'Tejnaksh Healthcare Private Limited' on 18 February, 2008 as a Private Limited Company. Company was converted to a Public Limited Company and the name was changed to 'Tejnaksh Healthcare Limited' vide fresh Certificate of Incorporation dated 10 March, 2015 issued by the Registrar of Companies, Mumbai, Maharashtra.

The Company run an Institute of Urology, an ISO certified the international level Urology hospital, located in Dhule, Maharashtra. It provides a comprehensive range of services from consultations and investigations to treatment for Urology. The main objective of Hospital namely Institute of Urology is to provide the people of Khandesh region of Maharashtra, the services of a super specialty hospital at an affordable rate.

Initiated with a vision to strengthen healthcare in rural India, the Company started its journey from Institute of Urology, a state of the art flagship, kidney care center in Dhule in the year 2003. A recognized teaching institute by the Ministry of Health and Family welfare, the Company provides quality healthcare services at 13 urology clinics, 4 urology hospitals and 2 dental super specialty clinics. The Company's achievements were the multiple records that motivates the customers to improve treatment for Urology.

In 2005, the Company started the 1st Urodynamics Lab of North Maharashtra. In 2006 , it established First Urology CME for the amily physicians. In 2007, it set up 1st Laser Unit and 1st Flexible Ureteroscope of North Maharashtra. In 2009, the Company was into Urology and healthcare training, recognized by The National Board of Examination.

In October 2015, the Company made a public issue of 3,04,000 Equity Shares of Rs 10/- each by raising funds aggregating to Rs. 2.44 Crores.

In 2015, the Company hosted the first PCNL workshop and became a public limited company. During the same year, the Company first dental speciality clinic took the initiative to set up The International Health Tourism. In 2016, the Company set up the first indigenous PCNL simulation lab in the country and were made commercially available during the year. The Company started Urology and Dental centers at Malegaon (MS), Sendhwa (MP) and a multi-speciality center in Navi Mumbai in 2016.

Parent organization Indian Private
NSE symbol [-]
Founded 2008
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Tejnaksh Healthcare Ltd?

Answer Field

The share price of Tejnaksh Healthcare Ltd for NSE is ₹ 0.00 and for BSE is ₹ 22.20.

What is the Market Cap of Tejnaksh Healthcare Ltd?

Answer Field

The market cap of Tejnaksh Healthcare Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 45.10 Cr. as of now.

What is the 52 Week High and Low of Tejnaksh Healthcare Ltd?

Answer Field

The 52 Week High and Low of Tejnaksh Healthcare Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 30.50 and ₹ 20.71.

How to Buy Tejnaksh Healthcare Ltd share?

Answer Field

You can trade in Tejnaksh Healthcare Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Tejnaksh Healthcare Ltd?

Answer Field

The 1 year returns on the stock has been -7.88%.

What is the Current Share Price of Tejnaksh Healthcare Ltd?

Answer Field

Tejnaksh Healthcare Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 22.20 as on Apr 30 2025 03:18 PM.

What is the Market Cap of Tejnaksh Healthcare Ltd Share?

Answer Field

The market cap of Tejnaksh Healthcare Ltd for NSE ₹ 0.0 & for BSE ₹ 45.10 as on Apr 30 2025 03:18 PM.

What is the P/E Ratio of Tejnaksh Healthcare Ltd Share?

Answer Field

As on Apr 30 2025 03:18 PM the price-to-earnings (PE) ratio for Tejnaksh Healthcare Ltd share is 18.20.

What is the PB ratio of Tejnaksh Healthcare Ltd Share?

Answer Field

As on Apr 30 2025 03:18 PM, the price-to-book (PB) ratio for Tejnaksh Healthcare Ltd share is 11.78.

How to Buy Tejnaksh Healthcare Ltd Share?

Answer Field

You can trade in Tejnaksh Healthcare Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Tejnaksh Healthcare Ltd Share on Bajaj Broking App?

Answer Field

To buy Tejnaksh Healthcare Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Tejnaksh Healthcare Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|